TrialThe Journal of dermatology2022

Metronidazole gel (0.75%) in Japanese patients with rosacea: A randomized, vehicle-controlled, phase 3 study.

Yoshiki Miyachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.